miR-542-3p is another biomarker of paclitaxel sensitivity in BC and has been documented to act on the antiapoptotic protein survivin leading to attenuated HER3/PI3K/Akt signaling, which enhanced paclitaxel cytotoxic activity in HER2-positive tumors [118]. This evidence concerns the gene ERBB2 and breast cancer.